These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35165727)

  • 1. Influence of tedizolid on the cytokine response to the endotoxin challenge in healthy volunteers: a cross-over trial.
    Jorda A; Wulkersdorfer B; Schörgenhofer C; Matzneller P; Al Jalali V; Bauer M; Wölf-Duchek M; Lackner E; Dorn C; Jilma B; Zeitlinger M
    J Antimicrob Chemother; 2022 Apr; 77(5):1424-1431. PubMed ID: 35165727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the human endotoxin challenge on tedizolid tissue penetration.
    Jorda A; Wulkersdorfer B; Schoergenhofer C; Matzneller P; Al Jalali V; Bauer M; Wölfl-Duchek M; Lackner E; Dorn C; Jilma B; Zeitlinger M
    Br J Clin Pharmacol; 2023 Jan; 89(1):416-420. PubMed ID: 36223278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Assessment of Tedizolid Pharmacokinetics and Tissue Penetration between Diabetic Patients with Wound Infections and Healthy Volunteers via
    Stainton SM; Monogue ML; Baummer-Carr A; Shepard AK; Nugent JF; Kuti JL; Nicolau DP
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of Tedizolid in Morbidly Obese and Covariate-Matched Nonobese Adults.
    Pai MP
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4585-9. PubMed ID: 27185808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary disposition of tedizolid following administration of once-daily oral 200-milligram tedizolid phosphate in healthy adult volunteers.
    Housman ST; Pope JS; Russomanno J; Salerno E; Shore E; Kuti JL; Nicolau DP
    Antimicrob Agents Chemother; 2012 May; 56(5):2627-34. PubMed ID: 22330925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide does not influence cytokines or exhaled NO in human experimental endotoxaemia.
    Soop A; Albert J; Weitzberg E; Bengtsson A; Nilsson CG; Sollevi A
    Clin Exp Immunol; 2004 Jan; 135(1):114-8. PubMed ID: 14678271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of tedizolid in subjects with renal or hepatic impairment.
    Flanagan S; Minassian SL; Morris D; Ponnuraj R; Marbury TC; Alcorn HW; Fang E; Prokocimer P
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6471-6. PubMed ID: 25136024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of Tedizolid and Pseudoephedrine Administered Alone or in Combination in Healthy Volunteers.
    Flanagan S; Minassian SL; Prokocimer P
    J Clin Med; 2018 Jun; 7(6):. PubMed ID: 29899212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetics, Exposure-Response, and Probability of Target Attainment Analyses for Tedizolid in Adolescent Patients with Acute Bacterial Skin and Skin Structure Infections.
    Li D; Sabato PE; Guiastrennec B; Ouerdani A; Feng HP; Duval V; De Anda CS; Sears PS; Chou MZ; Hardalo C; Broyde N; Rizk ML
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0089521. PubMed ID: 34516243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin and soft tissue concentrations of tedizolid (formerly torezolid), a novel oxazolidinone, following a single oral dose in healthy volunteers.
    Sahre M; Sabarinath S; Grant M; Seubert C; Deanda C; Prokocimer P; Derendorf H
    Int J Antimicrob Agents; 2012 Jul; 40(1):51-4. PubMed ID: 22584101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MMP-8 genotypes influence the inflammatory response in human endotoxemia.
    Rella JM; Jilma B; Fabry A; Kaynar AM; Mayr FB
    Inflammation; 2014 Apr; 37(2):451-6. PubMed ID: 24170307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, Safety, and Tolerability of Tedizolid Phosphate After Single-dose Administration in Healthy Korean Male Subjects.
    Kim Y; Kim A; Lee S; Choi SH; Lee DY; Song JS; Lee H; Jang IJ; Yu KS
    Clin Ther; 2017 Sep; 39(9):1849-1857. PubMed ID: 28865799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of Tedizolid in an Obese Patient after Bariatric Surgery.
    Grégoire M; Libois JB; Waast D; Gaborit B; Dauty M; Deslandes G; Dailly E; Touchais S; Boutoille D; Grégoire N; Couet W
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remote ischaemic preconditioning does not modulate the systemic inflammatory response or renal tubular stress biomarkers after endotoxaemia in healthy human volunteers: a single-centre, mechanistic, randomised controlled trial.
    Zwaag J; Beunders R; Warlé MC; Kellum JA; Riksen NP; Pickkers P; Kox M
    Br J Anaesth; 2019 Aug; 123(2):177-185. PubMed ID: 31084985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid.
    Flanagan S; Fang E; Muñoz KA; Minassian SL; Prokocimer PG
    Pharmacotherapy; 2014 Sep; 34(9):891-900. PubMed ID: 24989138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of glutamine infusion on the inflammatory response and HSP70 during human experimental endotoxaemia.
    Andreasen AS; Pedersen-Skovsgaard T; Mortensen OH; van Hall G; Moseley PL; Pedersen BK
    Crit Care; 2009; 13(1):R7. PubMed ID: 19173710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
    Zhanel GG; Love R; Adam H; Golden A; Zelenitsky S; Schweizer F; Gorityala B; Lagacé-Wiens PR; Rubinstein E; Walkty A; Gin AS; Gilmour M; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections.
    Shorr AF; Lodise TP; Corey GR; De Anda C; Fang E; Das AF; Prokocimer P
    Antimicrob Agents Chemother; 2015 Feb; 59(2):864-71. PubMed ID: 25421472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tedizolid and Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections of the Lower Extremity versus Non-Lower-Extremity Infections
    Joseph WS; Culshaw D; Anuskiewicz S; De Anda C; Prokocimer P
    J Am Podiatr Med Assoc; 2017 Jul; 107(4):264-271. PubMed ID: 27533787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro, in vivo, and clinical studies of tedizolid to assess the potential for peripheral or central monoamine oxidase interactions.
    Flanagan S; Bartizal K; Minassian SL; Fang E; Prokocimer P
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3060-6. PubMed ID: 23612197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.